Brain's endocannabinoid signaling pathway kept in check by two enzymes

November 25, 2009 by Sathya Achia Abraham

( -- A research team has shown that blocking the degradation of two naturally occurring cannabinoids in the endocannabinoid signaling pathway of the brain produces marijuana-like behavioral effects in mice, according to new findings published in the Proceedings of the National Academy of Sciences.

The endocannabinoid system regulates physiological processes such as appetite, , inflammation and memory. By inhibiting the enzymes that are responsible for endocannabinoid breakdown, researchers may be able to develop a novel therapeutic approach to reducing pain that could have fewer side effects and less abuse potential than .

In a collaborative study, led by The Scripps Research Institute, together with Virginia Commonwealth University School of Medicine researchers, the team found that blocking the specific enzymes that degrade two primary, naturally occurring in the brain, anandamide and 2-AG, leads to elevated levels of these substances that then produce significant marijuana-like effects in mice. The marijuana-like effects were not observed when blocking the degradation of these endocannabinoids one at a time. The study was published online in the Early Edition the week of Nov. 16.

The two major enzymes responsible for the breakdown or degradation of anandamide and 2-AG are fatty acid amide hydrolase and monoacylglycerol lipase - both which have been investigated by the Scripps and VCU groups in joint National Institutes of Health funded grants.

“These results suggest that marijuana mimics the actions of the body’s natural endocannabinoids that are normally kept in check by enzymatic degradation,” said Aron Lichtman, Ph.D., professor in the VCU Department of Pharmacology and Toxicology and co-principal investigator on the VCU portion of the study. Lichtman’s co-principal investigator at VCU was Jenny Wiley, Ph.D., associate professor in the VCU Department of Pharmacology and Toxicology.

“This work represents the first report showing that simultaneously increasing the body’s two main endocannabinoids produces marijuana-like subjective effects, marijuana-like motor effects, and a greater reduction in pain than increasing either endocannabinoid alone,” he said.

According to Lichtman, the team examined several behavioral assays in mice including analgesia, THC-like subjective effects, and catalepsy. They observed that the body’s natural endogenous cannabinoid system is kept in check by fatty acid amide hydrolase and monoacylglycerol lipase.

“We have demonstrated that potential therapeutic, as well as untoward effects of marijuana's primary active ingredient, tetrahydrocannabinol, or THC, represent points of crosstalk between endogenous anandamide and 2-AG signaling pathways in vivo,” he added.

This work builds upon the team’s previously published findings in the December 2008 issue of Nature Chemical Biology, which described the development of a drug, JZL184, that selectively blocks the degradation of 2-AG. In the present study, the team developed and tested a new compound, JZL195 that inhibits the degradation of both anandamide and 2-AG.

The endocannabinoid system consists of three components including two endogenous cannabinoids - anandamide and 2-AG - which are marijuana-like chemicals; enzymes that regulate the biosynthesis and breakdown of these endogenous cannabinoids; and two different types of receptors that are activated by anandamide and 2-AG, as well as the primary active ingredient in marijuana, THC. The endocannabinoid system is present throughout the brain and body and has been shown to modulate many important physiological processes in the brain and body, including pain, cognitive processes, anxiety, feeding, lipid synthesis, epilepsy, and inflammatory states in the brain, gastrointestinal tract and periphery.

Provided by Virginia Commonwealth University (news : web)

Explore further: Marijuana-like brain chemicals work as antidepressant

Related Stories

Researchers define new painkilling chemical pathway

November 23, 2008

Marijuana kills pain by activating a set of proteins known as cannabinoid receptors, which can also regulate appetite, inflammation, and memory. The body also has chemicals known as endocannabinoids that naturally activate ...

The body's own 'marijuana' is good for the skin

July 2, 2008

Scientists from Hungary, Germany and the U.K. have discovered that our own body not only makes chemical compounds similar to the active ingredient in marijuana (THC), but these play an important part in maintaining healthy ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Cow embryos reveal new type of chromosome chimera

May 27, 2016

I've often wondered what happens between the time an egg is fertilized and the time the ball of cells that it becomes nestles into the uterine lining. It's a period that we know very little about, a black box of developmental ...

Shaving time to test antidotes for nerve agents

February 29, 2016

Imagine you wanted to know how much energy it took to bike up a mountain, but couldn't finish the ride to the peak yourself. So, to get the total energy required, you and a team of friends strap energy meters to your bikes ...


Adjust slider to filter visible comments by rank

Display comments: newest first

5 / 5 (1) Nov 26, 2009
how long till the inhibitors hit the local street corner?
not rated yet Nov 26, 2009
Does this mean we could legally and safely get wasted, lol.
not rated yet Nov 27, 2009
"fatty" acid amide hydrolase - giggle, snicker

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.